Invasive Candida guilliermondii infection: In vitro susceptibility studies and molecular analysis

J. A. Vazquez, T. Lundstrom, L. Dembry, P. Chandrasekar, D. Boikov, M. B. Perri, M. J. Zervos

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Candida guilliermondii is rarely isolated from humans. We describe a case of disseminated C. guilliermondii with associated purulent pericarditis, despite high-dose amphotericin B (AmB), in a 19-year-old female with aplastic anemia who underwent BMT. In vitro susceptibility studies of the 13 clinical isolates, two control strains and one environmental isolate revealed a minimum inhibitory concentration (MIC) range of (0.19-1.56 μg/ml) for AmB and (1.25-10 μg/ml) for fluconazole. Pulsed-field gradient gel electrophoresis was performed to evaluate possible similarities between strains. This case is significant for several reasons, the high degree and prolonged duration of fungemia despite high-dose AmB and concomitant flucytosine, the change in in vitro susceptibility during therapy, the initial misidentification of the yeast isolate, and the invasiveness of the organism. The poor response to therapy may have been due to the severe and sustained neutropenia and the high MICs of C. guilliermondii to AmB.

Original languageEnglish (US)
Pages (from-to)849-853
Number of pages5
JournalBone marrow transplantation
Volume16
Issue number6
StatePublished - Dec 1 1995

Fingerprint

Amphotericin B
Candida
Infection
Fungemia
Flucytosine
Pericarditis
Aplastic Anemia
Fluconazole
Pulsed Field Gel Electrophoresis
Microbial Sensitivity Tests
Neutropenia
Yeasts
In Vitro Techniques
Therapeutics

Keywords

  • Allograft
  • Aplastic anemia
  • Candida

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Vazquez, J. A., Lundstrom, T., Dembry, L., Chandrasekar, P., Boikov, D., Perri, M. B., & Zervos, M. J. (1995). Invasive Candida guilliermondii infection: In vitro susceptibility studies and molecular analysis. Bone marrow transplantation, 16(6), 849-853.

Invasive Candida guilliermondii infection : In vitro susceptibility studies and molecular analysis. / Vazquez, J. A.; Lundstrom, T.; Dembry, L.; Chandrasekar, P.; Boikov, D.; Perri, M. B.; Zervos, M. J.

In: Bone marrow transplantation, Vol. 16, No. 6, 01.12.1995, p. 849-853.

Research output: Contribution to journalArticle

Vazquez, JA, Lundstrom, T, Dembry, L, Chandrasekar, P, Boikov, D, Perri, MB & Zervos, MJ 1995, 'Invasive Candida guilliermondii infection: In vitro susceptibility studies and molecular analysis', Bone marrow transplantation, vol. 16, no. 6, pp. 849-853.
Vazquez JA, Lundstrom T, Dembry L, Chandrasekar P, Boikov D, Perri MB et al. Invasive Candida guilliermondii infection: In vitro susceptibility studies and molecular analysis. Bone marrow transplantation. 1995 Dec 1;16(6):849-853.
Vazquez, J. A. ; Lundstrom, T. ; Dembry, L. ; Chandrasekar, P. ; Boikov, D. ; Perri, M. B. ; Zervos, M. J. / Invasive Candida guilliermondii infection : In vitro susceptibility studies and molecular analysis. In: Bone marrow transplantation. 1995 ; Vol. 16, No. 6. pp. 849-853.
@article{f7009d08d8d0423fb69127d641a54ea5,
title = "Invasive Candida guilliermondii infection: In vitro susceptibility studies and molecular analysis",
abstract = "Candida guilliermondii is rarely isolated from humans. We describe a case of disseminated C. guilliermondii with associated purulent pericarditis, despite high-dose amphotericin B (AmB), in a 19-year-old female with aplastic anemia who underwent BMT. In vitro susceptibility studies of the 13 clinical isolates, two control strains and one environmental isolate revealed a minimum inhibitory concentration (MIC) range of (0.19-1.56 μg/ml) for AmB and (1.25-10 μg/ml) for fluconazole. Pulsed-field gradient gel electrophoresis was performed to evaluate possible similarities between strains. This case is significant for several reasons, the high degree and prolonged duration of fungemia despite high-dose AmB and concomitant flucytosine, the change in in vitro susceptibility during therapy, the initial misidentification of the yeast isolate, and the invasiveness of the organism. The poor response to therapy may have been due to the severe and sustained neutropenia and the high MICs of C. guilliermondii to AmB.",
keywords = "Allograft, Aplastic anemia, Candida",
author = "Vazquez, {J. A.} and T. Lundstrom and L. Dembry and P. Chandrasekar and D. Boikov and Perri, {M. B.} and Zervos, {M. J.}",
year = "1995",
month = "12",
day = "1",
language = "English (US)",
volume = "16",
pages = "849--853",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Invasive Candida guilliermondii infection

T2 - In vitro susceptibility studies and molecular analysis

AU - Vazquez, J. A.

AU - Lundstrom, T.

AU - Dembry, L.

AU - Chandrasekar, P.

AU - Boikov, D.

AU - Perri, M. B.

AU - Zervos, M. J.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - Candida guilliermondii is rarely isolated from humans. We describe a case of disseminated C. guilliermondii with associated purulent pericarditis, despite high-dose amphotericin B (AmB), in a 19-year-old female with aplastic anemia who underwent BMT. In vitro susceptibility studies of the 13 clinical isolates, two control strains and one environmental isolate revealed a minimum inhibitory concentration (MIC) range of (0.19-1.56 μg/ml) for AmB and (1.25-10 μg/ml) for fluconazole. Pulsed-field gradient gel electrophoresis was performed to evaluate possible similarities between strains. This case is significant for several reasons, the high degree and prolonged duration of fungemia despite high-dose AmB and concomitant flucytosine, the change in in vitro susceptibility during therapy, the initial misidentification of the yeast isolate, and the invasiveness of the organism. The poor response to therapy may have been due to the severe and sustained neutropenia and the high MICs of C. guilliermondii to AmB.

AB - Candida guilliermondii is rarely isolated from humans. We describe a case of disseminated C. guilliermondii with associated purulent pericarditis, despite high-dose amphotericin B (AmB), in a 19-year-old female with aplastic anemia who underwent BMT. In vitro susceptibility studies of the 13 clinical isolates, two control strains and one environmental isolate revealed a minimum inhibitory concentration (MIC) range of (0.19-1.56 μg/ml) for AmB and (1.25-10 μg/ml) for fluconazole. Pulsed-field gradient gel electrophoresis was performed to evaluate possible similarities between strains. This case is significant for several reasons, the high degree and prolonged duration of fungemia despite high-dose AmB and concomitant flucytosine, the change in in vitro susceptibility during therapy, the initial misidentification of the yeast isolate, and the invasiveness of the organism. The poor response to therapy may have been due to the severe and sustained neutropenia and the high MICs of C. guilliermondii to AmB.

KW - Allograft

KW - Aplastic anemia

KW - Candida

UR - http://www.scopus.com/inward/record.url?scp=0029560440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029560440&partnerID=8YFLogxK

M3 - Article

C2 - 8750282

AN - SCOPUS:0029560440

VL - 16

SP - 849

EP - 853

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 6

ER -